ArticleFrontiers in oncology2026

Case Report: Personalized therapy in gynecological neuroendocrine neoplasm: a case of BRCA2-mutated ovarian neuroendocrine carcinoma treated with PARP-inhibitor.

Mara Mantiero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.